Study identifies new therapeutic targets to combat MS progression
Researchers have identified six specific proteins that could serve as therapeutic targets for treating progressive multiple sclerosis. The study suggests these proteins may help in developing new drugs or repurposing existing ones to address neurodegeneration.
Why it matters
Current MS treatments primarily target inflammation rather than the chronic neurodegeneration that causes long-term disability, making these findings critical for future drug development.
6 cellular markers that could lead to novel or repurposed treatments
The article reports on scientific findings from a peer-reviewed journal without political or social commentary.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in